ArticleRSC advances2025
Microfluidic chip designs and their application for E antigen typing on red blood cells.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Controlling the Mixing Performance of Passive Micromixers with Variable Section Units.Micromachines · 2026Article
- A Review on Micromixers, Microdroplet Generators and Their Integration.Micromachines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The E antigen is one of the main Rh antigens on red blood cells (RBCs). The high ability of the E antigen to trigger an immune response along with the presence of anti-E, can cause serious issues such as hemolytic transfusion reactions and hemolytic disease in newborns. In this study, we developed a microfluidic biochip for Rh typing (E antigen). Three different micromixer types were compared for simulation, mixing tests, and optimal interactions of blood typing reagents and RBCs to provide an accurate agglutination reaction. Using separate syringe pumps, a blood sample and anti-E reagent were introduced into the microfluidic device through the respective inlet channels. Then, the fluids underwent thorough mixing within the micromixers before reaching reaction reservoirs where RBC agglutination was observed. The 8-shape micromixer design showed the most agglutination and indicated the best performance for E antigen detection and was able to differentiate blood clinical samples with E-positive and -negative RBCs. The microfluidic chip could also be applied for RBC antigen detection in blood bank procedures during blood typing and compatibility testing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.